Bifogade filer
PDF
Kurs
+1,01%
Likviditet
0,04 MSEK
Kalender
| Tid* | ||
| 2025-02-26 | 08:30 | Bokslutskommuniké 2024 |
| 2024-11-26 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-10 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2024-05-08 | - | Årsstämma |
| 2024-05-08 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-27 | - | Bokslutskommuniké 2023 |
| 2023-11-09 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-29 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2023-05-09 | - | Årsstämma |
| 2023-05-09 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-27 | - | Bokslutskommuniké 2022 |
| 2022-11-09 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-29 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-03 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2022-05-02 | - | Årsstämma |
| 2022-05-02 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-28 | - | Bokslutskommuniké 2021 |
| 2021-11-09 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-24 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | - | Årsstämma |
| 2021-05-05 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2021-05-03 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-19 | - | Extra Bolagsstämma 2021 |
| 2021-02-28 | - | Bokslutskommuniké 2020 |
| 2020-12-18 | - | Extra Bolagsstämma 2020 |
| 2020-11-09 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-24 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-23 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2020-06-22 | - | Årsstämma |
| 2020-05-04 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-25 | - | Bokslutskommuniké 2019 |
| 2019-11-18 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-26 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-07 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2019-05-06 | - | Årsstämma |
| 2019-05-06 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-26 | - | Bokslutskommuniké 2018 |
| 2018-08-27 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-08 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2018-05-07 | - | Årsstämma |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-09-25 | - | Extra Bolagsstämma 2017 |
| 2017-08-28 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-06 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2017-04-05 | - | Årsstämma |
| 2017-02-22 | - | Bokslutskommuniké 2016 |
| 2016-10-26 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-09 | - | Årsstämma |
| 2016-05-09 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-23 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2016-02-22 | - | Bokslutskommuniké 2015 |
| 2015-11-27 | - | Kvartalsrapport 2015-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Redsense Medical AB has been qualified and approved to enter share trading on the OTCQX trading platform in the United States. Trading of the share on OTCQX will start September 29, 2023 under the symbol "RDSNF".
OTCQX is a trading platform in the United States operated by the OTC Markets Group for securities not listed on a national stock exchange. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"We are excited to now offer U.S. investors the opportunity to begin trading the Redsense Medical share. Furthermore, through a cross-trade on OTCQX, we make it easier for international investors and institutions who are considering trading our shares. With most of our revenue in the U.S. and our strong focus on this market, the dual-quotation is a natural step to meet an increased interest in Redsense Medical", says Pontus Nobréus, CEO of Redsense Medical AB.
B. Riley Securities Inc. acted as the company's OTCQX sponsor.
For more information, please contact:
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com
Redsense Medical AB (publ), 556646-4862